Fongit

BrainScape Medical is a Swiss life sciences startup focused on developing an end-to-end solution for brain disorder management and care, addressing many limitations of current approaches.

Miloo is a Swiss company specializing in high-performance electric bikes tailored for urban mobility. The company designs and assembles its vehicles in Switzerland, ensuring they meet the highest standards of safety and performance. Miloo's e-bikes are engineered to enhance the commuting experience, offering riders a stylish and powerful alternative to traditional transport methods. With a focus on sustainability and user comfort, Miloo's electric bikes provide extended range and connectivity, allowing individuals to navigate city life with ease. By combining innovative design with advanced technology, Miloo aims to redefine urban transportation, promoting a cleaner and more agile form of mobility.

Cerret, a Swiss-based jewelry brand, specializes in designing and manufacturing smart bracelets for women's safety. Their products, equipped with advanced technology, allow users to discreetly alert loved ones or authorities in case of an emergency, providing a sense of security and peace of mind.

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

Antion Biosciences SA is a biotechnology company based in Geneva, Switzerland, specializing in cell and gene engineering. The company focuses on developing off-the-shelf therapies to address diseases with significant unmet medical needs. Utilizing its proprietary technology, Antion enables a modular and tunable approach to multiplex engineering of therapeutic cells. Recently, the company has shifted its efforts to repurpose its miCAR19 developments for autoimmune diseases, leveraging in vivo proof-of-concept data from its lead product, miCAR7. Antion is distinguished by its allogeneic solutions and aims to deliver a best-in-class product specifically targeting B-cell-driven autoimmune diseases. With substantial preclinical advancements already achieved, the next critical step for the company is to establish proof-of-concept in human trials.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

KYLYS is a Swiss company located in Geneva, founded in March 2017, that specializes in the development of innovative biomolecule-based products to address medical, surgical, and cosmetic needs. The company offers a unique line of hyaluronic acid pearls, which are biocompatible and biodegradable gels that can be easily injected at room temperature. These gels have the capability to form microgel structures within the tissue at body temperature, ensuring a durable effect while preventing migration from the injection site. By focusing on safety and efficacy, KYLYS aims to provide healthcare providers with effective solutions for their patients.

Plair SA is a Swiss company specializing in the development and manufacturing of advanced systems for preventive environmental monitoring, particularly focusing on air quality. Founded in 2014 and based in Plan-les-Ouates, Switzerland, Plair SA designs instruments that enable continuous real-time measurements of fine airborne particles. Its notable products include the Rapid-E, which analyzes single aerosol particles, and the Particle Analyzer PA-300, capable of detecting, identifying, and classifying various airborne entities such as pollen, fungal spores, soot, and pollutants. The company offers solutions for airborne allergen monitoring, air quality assessment, and bioaerosol tracking, providing crucial data on atmospheric aerosol concentrations. Plair SA originated as a spin-off from the University of Geneva, reflecting its strong foundation in research and innovation.

Endotelix is a privately held Swiss biotech start-up and a spin-off from the University of Geneva, focused on developing innovative solutions for Antiphospholipid Syndrome. The company specializes in creating diagnostic products and therapies aimed at detecting circulating antibodies associated with the condition. By providing fast, sensitive, and reliable diagnostic tests, Endotelix aims to enhance healthcare outcomes for vulnerable populations, including pregnant women and adolescent children. The company is committed to reducing pregnancy-related complications and improving overall healthcare delivery through its advanced research and diagnostic tools.

EBAMed SA is a Swiss startup based in Geneva that specializes in developing innovative medical devices for the non-invasive treatment of heart arrhythmias. Founded in 2018, the company focuses on creating an ultrasound-based device that utilizes proton therapy to monitor heart motion and synchronize therapeutic beams in real time. This technology allows for the precise delivery of radiation treatment to targeted heart tissues, thereby expanding treatment options for existing proton therapy centers and enabling them to treat heart patients effectively. By providing a non-invasive approach to cardiac care, EBAMed aims to improve patient outcomes and streamline treatment processes in outpatient settings.

Terapet SA is a Switzerland-based company founded in 2019 at CERN by physicists Christina Vallgren and Marcus Palm, along with Professor Raymond Miralbell from the Geneva University Hospitals. The company specializes in developing advanced proton therapy technology for cancer treatment, which allows for precise targeting of tumors while minimizing damage to surrounding healthy tissue. This innovative approach leverages the unique properties of protons, which stop at a predetermined depth within the patient, enabling the delivery of a concentrated dose to the tumor. Terapet's system also provides real-time, three-dimensional monitoring of the proton dose administered, enhancing treatment accuracy and safety. With a focus on making cutting-edge cancer therapy more accessible and cost-effective, Terapet is preparing for the market launch of its initial product.

Transmutex is a Swiss company founded in 2019 that specializes in innovative nuclear technology aimed at significantly reducing existing nuclear waste. The company leverages advanced techniques, including particle accelerators, to transmute long-lived nuclear waste into less harmful materials while simultaneously generating carbon-free energy. This energy can be reintegrated into the power grid or utilized for green hydrogen production. Comprising a diverse team of physicists, computer scientists, and environmentalists, Transmutex is pioneering a new approach to nuclear energy that offers scalable, carbon-free solutions without the typical challenges associated with conventional nuclear power plants.

GliaPharm SA is a Swiss biotechnology company focused on developing innovative treatments for neurological and psychiatric disorders. Established in 2016 and headquartered in Geneva, GliaPharm specializes in targeting glial cells, which are the support cells of neurons, to enhance brain metabolism in pathological conditions. The company utilizes its GliaX technology platform to identify drugs that influence glial cell activity and brain energy metabolism. This platform incorporates high throughput screening technologies, metabolic tests for in vitro and in vivo assessments, and various rodent models to study neurological diseases such as Alzheimer's disease, amyotrophic lateral sclerosis, and other psychiatric conditions. Through its research and development efforts, GliaPharm aims to provide healthcare providers with novel therapeutic options for patients suffering from these disorders, positioning itself as a leader in glia-mediated neuroprotection and cognitive function maintenance.

ABCDx SA is a privately-funded company based in Geneva, Switzerland, founded in 2014 by three experts in the field of brain biomarkers. The founders include two prominent researchers from the Faculty of Medicine at the University of Geneva and the Vall d’Hebron Research Institute, who are recognized for their contributions to biomarker discovery and validation. The third founder brings extensive experience in the diagnostic and pharmaceutical industries. ABCDx specializes in the development and validation of biomarker and biomarker panel tests aimed at enhancing the diagnosis and treatment of brain injuries. The company's offerings are designed to identify and assess patients at risk of severe long-term complications stemming from traumatic injuries, strokes, and post-stroke infections. Through its innovative approach, ABCDx aims to improve patient outcomes in the realm of brain health.

HekeTiss SA is a spin-off from the University Hospitals of Geneva and the University of Geneva, specializing in the manufacturing of medical and dental instruments. The company has developed TrophiPatch, an innovative cellular patch designed to enhance wound healing. This product closely resembles natural skin and is engineered from stem cells derived from human adipose tissue. TrophiPatch actively secretes various factors that facilitate the wound healing process, effectively restoring blood vessels in the affected area. By promoting efficient healing, HekeTiss aims to enable healthcare providers to offer effective and cost-efficient treatments for chronic ulcers while significantly reducing the time required for recovery.

HeroSupport is a medical device manufacturing company founded in 2019 and based in Veyrier, Geneva. The company specializes in creating medical immobilization devices designed to enhance patient comfort during clinical procedures. Its innovative technology transforms imaging and treatment tables into personalized support solutions, specifically catering to the needs of patients undergoing prone breast radiotherapy. This approach allows patients to benefit from tailored support, eliminating the need for them to adjust to the standard table. By improving patient comfort, HeroSupport enables healthcare providers to deliver more effective and cost-efficient cancer treatment.

CommoChain SA is a Swiss company founded in 2018, specializing in a fintech platform that facilitates commodity trading. Headquartered in Plan-les-Ouates, the company focuses on streamlining the back-office operations of exporters and importers of raw materials. By leveraging blockchain and smart contract technology, CommoChain enhances the security and efficiency of financial transactions associated with the international trade of commodities. Its platform aims to simplify, secure, and accelerate the execution of physical transactions, allowing companies to improve their operational efficiency in the global marketplace.

MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.

Kejako SA is a Swiss company, founded in 2015 and based in Plan-les-Ouates, that specializes in the research and development of medical devices for the ophthalmic surgery sector. The company focuses on addressing presbyopia, a condition that leads to the gradual loss of visual accommodation, through innovative solutions. Kejako offers a unique, non-invasive approach that combines simulation and minimally invasive treatment techniques, utilizing a full eye 3D parametric model and multi-physics numerical modeling to accurately compute the eye's optical and mechanical behavior. This technology enables patients to plan and control customized procedures aimed at preserving their quality of life as they age.

Alohi is a Swiss company founded in 2015 that offers a cloud-based communication platform tailored for entrepreneurs, small businesses, and individual consumers. The company provides a range of services, including local phone numbers in various countries, customizable greeting messages, call forwarding, voicemail, fax, and announcements. Alohi focuses on two primary platforms: one for self-service communications and another for legally binding electronic signatures. Its current products include Sign.Plus, Fax.Plus, and Scan.Plus, which facilitate electronic signing and verification of documents as well as secure online fax services. By enabling users to communicate efficiently and manage confidential documents safely, Alohi aims to enhance the way individuals and businesses interact.

MagicTomato operates an online grocery marketplace focused on providing locally sourced and made products. Established in September 2016 in the Geneva area, the company aims to promote sustainable grocery shopping by offering a range of non-industrial and GMO-free items, including fruits, vegetables, meats, cheeses, and beverages. The marketplace features over 800 products sourced from a network of approximately 30 local artisans, ensuring ultimate freshness and quality. MagicTomato's business model emphasizes reducing food waste and packaging, while facilitating same-day delivery to customers. With a commitment to enhancing consumer access to healthy and smart grocery options, the company has achieved break-even status.

ProtonVPN is Swiss-based VPN service, created by the same team of CERN scientists who created ProtonMail. ProtonVPN makes it possible to access the Internet without censorship and surveillance.

Quantreex, founded in 2016 and based in Geneva, Switzerland, is a company that develops an AI-based trading platform. This platform enables users to create automated trading strategies quickly by leveraging machine learning and artificial intelligence to identify and exploit market opportunities. The system allows for the verification of financial strategies through backtesting across various instruments and markets, with the ability to implement these strategies live directly on the platform.

Gmelius Ltd is a software company based in Plan-les-Ouates, Switzerland, founded in 2016. It specializes in developing a plug-and-play email collaboration platform that transforms traditional email inboxes into comprehensive workspaces. Gmelius integrates seamlessly with Google Workspace and connects with other popular tools like Slack and Trello, allowing teams to manage projects and automate workflows without the need for extensive training or data migration. Its features include email tracking, project management, email delegation, shared labels, and Kanban boards, all designed to enhance productivity and collaboration. Gmelius serves over 10,000 paid customers, including notable firms such as Netflix and JustWorks, by facilitating real-time collaboration and unifying internal and external communications directly from email.

TwentyGreen is a Swiss company that specializes in the production of probiotic feed supplements aimed at enhancing sustainable animal farming practices. Founded in 2015 and based in Root, Switzerland, the company has developed a unique triple active probiotic product that addresses challenges faced in intensive animal farming, such as improving digestion, enhancing feed conversion ratios, and reducing disease and pollution. The probiotic supplement is grounded in research from the École Polytechnique Fédérale de Lausanne, focusing on the enhancement of gut microbiota, which is crucial for food metabolism and immune defense. Targeting animal farmers, feed suppliers, and large retailers, TwentyGreen aims to capture a 10% share of the rapidly growing global animal feed probiotic market, which exceeds $4 billion annually. The commercialization of their product involves rigorous research and development in collaboration with esteemed academic partners to meet regulatory standards for animal feed.

OrbiWise is a Swiss company specializing in advanced technologies for the Internet of Things (IoT) sector. Its primary product, OrbiWAN, is a carrier-grade network server designed for networks utilizing LoRa technology. This server enhances the performance of IoT services by enabling real-time device messaging and targeted device group profiling, effectively supporting a wide range of applications from smart city initiatives to rural and industrial environments. With a strong engineering foundation, OrbiWise's team possesses extensive expertise in wireless technology, cloud and embedded software, communication systems, and RF/hardware design. The company is committed to customer success and values innovation, technology, and integrity in all its operations.

Prodibi is a professional image platform based in Geneva, Switzerland, that addresses various challenges associated with online image display, enhancing brand ROI and user engagement. Established in 2011, the platform offers a subscription-based service that simplifies the process of sharing high-quality images on web and mobile. By automatically uploading, encoding, and delivering images, Prodibi allows photographers, artists, and web publishers to showcase their work without sacrificing speed or quality. The solution effectively resolves issues such as color management, pixel density, and responsiveness, which can be time-consuming and costly for graphic designers. Prodibi’s capabilities enable users to replace images seamlessly without the need for website redesigns or new photo shoots, delivering an exceptional visual experience that aligns with the prestige of their brands.

Expedismart is a courier service comparison platform based in Switzerland that facilitates the sending of mail and parcels both domestically and internationally. The company provides users with the ability to compare various courier services, allowing them to select the most suitable option for their shipping needs. Expedismart's platform emphasizes quality service, accurate booking, and preferred courier times, all while ensuring competitive pricing. By enabling customers to compare prices and book shipments online, Expedismart aims to streamline the shipping process and help individuals and businesses save on their parcel deliveries.

Silver Wave is a Swiss company based in Geneva, founded by expert professionals from the pharma & medical device industries. Building on 25 years of experience, the team at Silver Wave has a leading reputation in the field of aesthetics, with experience in research and development as well as manufacturing and management that extends to many global healthcare companies. Silver Wave is built on the team’s experience and passion.

Multiwave Technologies AG, headquartered in Geneva, Switzerland with a research and development facility in France, specializes in innovative medical imaging solutions. Established in March 2015, the company is renowned for its leadership in metamaterial MRI antenna design, aiming to enhance the quality of Magnetic Resonance Imaging (MRI) devices. Multiwave Technologies focuses on developing breakthrough MRI and Positron Emission Tomography (PET) devices, with a vision to create portable MRI technology.

Planet Intus SA is a Swiss company specializing in the design and development of indoor geolocation software. Founded in 2014 and headquartered in Carouge, Switzerland, the company leverages a combination of French telecommunications expertise and Swiss quality standards. Planet Intus provides both active and passive geolocation infrastructure, enabling a variety of indoor guidance services and applications for end users. Its offerings include preparation and navigation assistance, opportunity tracking, safety services, and marketing data analysis for professionals, enhancing customer experience in sectors such as retail, leisure, travel, and healthcare. The company's innovative 3D-integrated platform utilizes indoor positioning technologies and user behavior analysis, allowing clients to navigate locations like exhibitions efficiently. A team of skilled engineers and technicians supports Planet Intus, focusing on Geographic Information Systems, mobile app development, and big data analytics to deliver superior operational insights and profitability for businesses.

InvestGlass is a Swiss-based company founded in 2013, specializing in the development of a web-based platform that provides a comprehensive suite of tools for client and customer management, particularly in the financial sector. The platform integrates features such as digital onboarding, customer relationship management, portfolio management, and marketing automation, all designed to enhance operational efficiency for financial institutions and advisors. InvestGlass also offers a Strategy Tutor to assist investors in maintaining their investment strategies, alongside access to global market data, news, and forecasts. Additionally, an Educational Portal provides resources such as articles, tools, and videos aimed at improving market understanding. By leveraging artificial intelligence and a secure Swiss cloud infrastructure, InvestGlass helps clients navigate compliance challenges while focusing on delivering high-quality investment advice.

Telexoo is a Geneva-based company that offers an online financial platform for currency exchange at competitive rates. Unlike traditional services, Telexoo provides a more personal approach, allowing users to connect directly with exchange specialists via phone or email, eliminating the need for call centers or ticket systems. Users can create a free account on the platform to transfer funds from their bank for exchange. The transactions are executed in real-time based on the interbank rate, enabling users to send exchanged currency seamlessly to any destination. Telexoo focuses on providing accessible and efficient currency exchange services.

Aptissen SA, founded in 2013 as a spin-off of ANTEIS, is a Swiss company based in Plan-les-Ouates, specializing in the development and commercialization of hyaluronic acid polymer-based injectable medicinal products. The company focuses on aesthetic medicine, ophthalmology, and orthopedics, with notable innovations such as the Synolis VA range, which combines hyaluronic acid and sorbitol to provide rapid mobility recovery and effective pain relief for osteoarthritis patients. Aptissen also offers a food supplement called Cartylis aimed at joint health. Its products are distributed through a global network of distributors in over 50 countries, including Europe, South America, Canada, the Middle East, and Asia. The company operates subsidiaries in Italy, Poland, and France, and maintains certifications including CE, ISO13485, MDSAP, and GMP compliance, ensuring adherence to high-quality standards. Aptissen relies on subcontracting for production, sourcing materials from three suppliers located in Europe.